SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Moyle B.)
 

Sökning: WFRF:(Moyle B.) > (2023) > Prevalence of micro...

  • Parker, W. A. E.Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK (författare)

Prevalence of microspirometry-defined chronic obstructive pulmonary disease in two European cohorts of patients with significant smoking history hospitalised for acute myocardial infarction

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • BMJ Publishing Group Ltd,2023
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-112591
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-112591URI
  • https://doi.org/10.1136/thorax-2023-BTSabstracts.95DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:155148292URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:vet swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Introduction: Smoking is a major risk factor for both chronic obstructive pulmonary disease (COPD) and myocardial infarction (MI). Systemic inflammation also contributes to both diseases and has been suggested as a potential target for intervention. Prevalence of COPD in those with a significant smoking history hospitalised for MI has not been well-characterised. We sought to obtain an accurate estimate of COPD burden in this group and characterise the population.Methods: Two consecutive cohorts of patients hospitalised for MI with a smoking history of ≥10 pack-years were recruited in Sweden and the United Kingdom (UK). Baseline characteristics were recorded, including treatment with inhaled corticosteroids (ICS) and eosinophil count in blood. Microspirometry was performed using the Vitalograph COPD-6 device and symptom burden assessed using the COPD Assessment Test (CAT). The primary outcome was the prevalence of a preliminary diagnosis of clinically-significant COPD, here defined as a ratio of forced expiratory volume in 1 and 6 seconds (FEV1/FEV6) <0.7 and with FEV1 <80% of predicted value.Results: In the UK cohort, 216 participants with MI (26% female, median age 60 (IQR 53–67) years, smoking history 32 (23–45) pack-years) were recruited. The proportion with any COPD was 36%. Clinically-significant COPD was found in 30 participants (13.9%, 95% CI 9.5–19.2). Of these, 43% had a prior COPD diagnosis, 20% had an eosinophil count ≥300 cells/mm3, mean CAT score was 14.4 ± 9.3), 80% had high symptom burden (CAT score >10) and 23% were receiving ICS. The Swedish cohort included 302 participants with MI (24% female, median age 68 (IQR 61–76) years, 26 (15–38) pack years), and clinically-significant COPD was found in 52 (17.2%; 12.9–21.5). In these 52 participants, 17% had a prior COPD diagnosis, 20% had an eosinophil count ≥300 cells/mm3, mean CAT score was 12.9 ± 7.2, 63% had CAT score ≥10 and 15% had treatment with ICS.Conclusions: The prevalence of preliminary diagnosis of clinically-significant COPD in patients with a ≥10 pack-year smoking history hospitalised for MI is similar between two European cohorts and under-recognised. Further work is warranted to determine whether identification and treatment of COPD improves clinical outcomes following MI.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Sundh, Josefin,1972-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Respiratory Medicine(Swepub:oru)jnsh (författare)
  • Oldgren, J.Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (författare)
  • Konstantinidis, K. , VAstraZeneca, Cambridge, UK (författare)
  • Lindback, J.Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (författare)
  • Janson, C.Department of Medical Sciences, Uppsala University, Uppsala, Sweden (författare)
  • Andell, P.Unit of Cardiology, Department of Medicine, Karolinska Institute, Stockholm, Sweden; Heart and Vascular Division, Karolinska University Hospital, Stockholm, Sweden (författare)
  • Björkenheim, Anna,1980-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Cardiology(Swepub:oru)anbm (författare)
  • Elamin, N.Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK (författare)
  • McMellon, H.Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK (författare)
  • Moyle, B.Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK (författare)
  • Patel, M.AstraZeneca, Cambridge, UK (författare)
  • El Khoury, J.AstraZeneca, Cambridge, UK (författare)
  • Surujbally, R.AstraZeneca, Cambridge, UK (författare)
  • Storey, R. F.Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK (författare)
  • James, S.Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (författare)
  • Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UKInstitutionen för medicinska vetenskaper (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Thorax: BMJ Publishing Group Ltd78:Suppl. 4, s. A66-A660040-63761468-3296

Internetlänk

Hitta via bibliotek

  • Thorax (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy